The House Appropriations Committee passed a measure that blocks State Department funding for a nonprofit organization that charges Americans with being "opponents of aid to Ukraine."
Cloud seeding is an unfamiliar topic to many U.S. citizens, especially those outside of drought-stricken regions of America.
Beyond the image of a factory producing...
In response to the growing worry among voters about immigration in the 2024 presidential contest, President Joe Biden signed an executive order on Tuesday...
It was an unusually warm day in the seaside town of Portoroz, and Leida Ruvina was growing suspicious. The doctoral program she had been enrolled in for weeks had all the signs of a sham—the campus was a small, shabby building rented out from a tourist school and the French translation for “Euro-Mediterranean” in the university’s seal was misspelled.
Ruvina raised her hand to ask the university’s president what was going on, and he assured her that everything was in order. He then complimented her on her fluent English and offered to advise her on her dissertation thesis. “If you want, I can be your mentor,” she recalled him telling her in an awkward exchange as he steered the conversation away from questions about the university’s legitimacy.
Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial virus (RSV).
